- Moderna vaccine trial hits key goal to measure the advantages of Shot Bloomberg
- In clinical trials, Moderna’s cancer vaccine score is very complicated
- Moderna says the company has enough cases to analyze its Covid-19 vaccine trial CNBC TV
- Moderna stock rises as the first set of COVID-19 vaccine data is ready for analysis MarketWatch
- Latest news on the coronavirus pandemic: real-time updates from CNN International
- View all reports from Google News
Source link
